You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. PLASMA & BIOTHERAPIES - 05-02-2015

    SIPPET Study: interim analysis confirms the original hypothesis

    The Study on inhibitors in Hemophilia A is safe to continue after Investigators’ Meeting in San Francisco (Dec 2014)

    read more 
For more information please contact: pressoffice@kedrion.com